Clinical Trials Logo

Filter by:
NCT ID: NCT01110915 Completed - Clinical trials for Magnetic Resonance Imaging

Advisa MRI Clinical Study

Start date: June 2010
Phase: N/A
Study type: Interventional

The purpose of the Advisa MRI System clinical study is to confirm safety and effectiveness in the clinical MRI (Magnetic Resonance Imaging) environment when subjects receive MRI scans up to 2W/kg Specific Absorption Rate (SAR) without positioning restrictions (MRI scans may occur anywhere on the body including the chest).

NCT ID: NCT01110785 Recruiting - Colorectal Cancer Clinical Trials

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

Start date: April 2010
Phase: Phase 2
Study type: Interventional

RATIONALE: Simvastatin may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as panitumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Giving simvastatin together with panitumumab may kill more tumor cells. PURPOSE: This phase II trial is studying how well simvastatin given together with panitumumab works in treating patients with advanced or metastatic colorectal cancer.

NCT ID: NCT01110369 Completed - Sarcopenia Clinical Trials

A Protein Supplementation and Exercise Strategy to Promote Muscle Protein Anabolism in Frail Elderly People

ProMuscle
Start date: November 2009
Phase: N/A
Study type: Interventional

The present study is designed to investigate whether timed protein supplementation will increase skeletal muscle mass in the frail elderly population.

NCT ID: NCT01110122 Recruiting - Muscle Damage Clinical Trials

Effect of Whey Protein on Soccer Performance

Start date: March 2010
Phase: N/A
Study type: Interventional

Rationale: During exercise protein breakdown in muscles is larger than protein synthesis. This negative muscle protein balance leads to increased muscle damage and thereby to a reduced muscle tissue recovery. To achieve a positive muscle protein balance and reduce muscle damage, many athletes use proteins. In professional soccer players, considerable stress is placed on the musculoskeletal system. Recovery time is often too short for these players to restore homeostasis, which results in catabolic processes. This increases playing errors and will lead to lapses in concentration. Therefore, it is of great importance for a professional soccer team to be in optimal condition and a fast recovery after exercise is desirable to accomplish maximum performance. Supplementation with whey proteins is thought to support this. Objective: To assess whether post-exercise supplementation with whey protein will lead to a better muscle recovery than supplementation with carbohydrates in Dutch soccer players between the age of 15 and 18 years old. Study design: A double blind randomised controlled cross-over trial. Study population: Healthy soccer players of the A and B selection of AJAX between the age of 15 and 18 years old. Intervention: Supplement, containing either whey proteins or an isocaloric carbohydrate placebo. Each supplement will be administered for 2 weeks separated by a 7 day washout period. Treatment order will be randomly assigned. Main study parameters: The main study parameter will be the Yo-Yo intermittent recovery test level 2 score and the vertical jump test. The scores will evaluate the soccer players' ability to repeatedly perform intense exercise and his potential to recover from this exercise.

NCT ID: NCT01110070 Terminated - Cartilage Defect Clinical Trials

ChonDux for Filling Full Thickness Cartilage Defects in the Femoral Condyle of the Knee

Start date: July 2010
Phase: N/A
Study type: Interventional

The use of ChonDux Cartilage Repair system for the treatment of single cartilage lesions in the femoral condyle of the knee. The primary outcome measure is degree of lesion fill at 6 months. Filling of the femoral chondral defect of the knee using ChonDux™ Cartilage System may give symptomatic relief of pain and help to restore knee function. Included in this study is pain relief using Visual Analog Scale (VAS), knee function using the International Knee Documentation Committee (IKDC) questionnaire and quality of life using the Short Form-36 (SF-36) survey.

NCT ID: NCT01109940 Completed - Clinical trials for Ankylosing Spondylitis

Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing Spondylitis

Start date: April 2010
Phase: Phase 2
Study type: Interventional

This study is designed as an extension study to the proof-of-concept trial CAIN457A2209 in patients with moderate to severe ankylosing spondylitis and aims to provide continuous treatment with AIN457 for patients in the core trial, to obtain safety and tolerability information. The study will address the evaluation of efficacy following doses of Intravenous infusion (IV) of 3 mg/kg AIN457 given every 4 weeks over a period initially up to 6 months (Part 1) and based on the risk/benefit balance of AIN457 in ankylosing spondylitis a decision was taken to continue dosing for another 6 month period (Part 2).

NCT ID: NCT01109914 Completed - Clinical trials for Kidney Transplantation

Mucosal Response in Immunocompromised Host

MICH
Start date: April 2010
Phase: Phase 4
Study type: Interventional

The aim of this study is to verify whether vaccination with Dukoral® (SBL Vaccines) induces an immune response in renal transplant recipients on prednisolone in combination with either a calcineurin inhibitor CNI) or mycophenolate mofetil (MMF).

NCT ID: NCT01109745 Completed - Asthma Clinical Trials

Effectiveness of the Pelican Instrument in Medical Care

PELICANII
Start date: August 2011
Phase: N/A
Study type: Interventional

The objective of this project is to establish the effectiveness of implementation of a self-administered electronic asthma-specific quality of life instrument for childhood asthma in primary care and specialist care.

NCT ID: NCT01109628 Completed - Sarcopenia Clinical Trials

Protein Supplementation to Promote Muscle Protein Anabolism in Frail Elderly People

ProMuscle
Start date: November 2009
Phase: N/A
Study type: Interventional

The present study is designed to investigate whether timed protein supplementation will increase skeletal muscle mass in the frail elderly population.

NCT ID: NCT01108887 Completed - Clinical trials for Multiple Sclerosis, Relapsing-Remitting

An Observational Study for the Assessment of Adherence, Effectiveness and Convenience of Rebif® Treatment in Relapsing Multiple Sclerosis Patients Using RebiSmart™.

SMART
Start date: September 2009
Phase: N/A
Study type: Observational

RebiSmart™ is a device with an electronic injection log to monitoring adherence to therapy. Therefore RebiSmart is a tool for administering Rebif in multi-dose cartridges that may improve patient satisfaction and adherence to therapy. The objectives of this study are to evaluate adherence, effectiveness and convenience of treatment in subjects with relapsing multiple sclerosis (RMS) using RebiSmart to self-inject Rebif in a multi-dose cartridge.